Literature DB >> 619707

Platelet aggregation following heparin and protamine administration.

N Ellison, L H Edmunds, R W Colman.   

Abstract

The effects of heparin, protamine, and the heparin-protamine complex on the abilities of platelets to aggregate in vitro in response to adenosine diphosphate (ADP) and epinephrine were determined. Citrated blood was obtained from normal volunteers and portions were treated with heparin, protamine, and three different ratios of heparin and protamine. The threshold concentrations of ADP and epinephrine required to produce complete platelet aggregation were then determined. Compared with control citrated plasma, the geometric mean of the threshold concentration for ADP in the heparinized sample was decreased twofold, from 1.88 to 0.94 micrometer; and that for epinephrine more than threefold, from 0.5 to 0.14 micrometer. In contrast, the threshold concentration for ADP was increased to 3.68 micrometer in the neutralized and to 2.78 micrometer in the overneutralized samples and that for epinephrine to 1.62 micrometer in the neutralized and 1.82 micrometer in the overneutralized samples. These data indicate that heparin increases the sensitivity of platelets to ADP and epinephrine as determined by platelet aggregation, and protamine added to heparinized blood not only reverses this effect, but decreases platelet sensitivity when it is added in concentration that neutralize heparin. Additional protamine has no further effect, and protamine alone has no effect on platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 619707     DOI: 10.1097/00000542-197801000-00008

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  Clinical role of blood heparin level monitoring during open heart surgery.

Authors:  T Ohata; Y Sawa; S Ohtake; M Nishimura; C J Chan; K Suzuki; H Matsuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-12

Review 2.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

3.  Platelet reactivity in patients with chronic kidney disease and hemodialysis.

Authors:  Philipp Mourikis; Carolin Helten; Lisa Dannenberg; Thomas Hohlfeld; Johannes Stegbauer; Tobias Petzold; Bodo Levkau; Tobias Zeus; Malte Kelm; Amin Polzin
Journal:  J Thromb Thrombolysis       Date:  2020-01       Impact factor: 2.300

Review 4.  Effect of heparin and heparin fractions on platelet aggregation.

Authors:  E W Salzman; R D Rosenberg; M H Smith; J N Lindon; L Favreau
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

5.  Heparin modulates the conformation and signaling of platelet integrin αIIbβ3.

Authors:  Mayumi Yagi; Jacqueline Murray; Kurt Strand; Scott Blystone; Gianluca Interlandi; Yasuo Suda; Michael Sobel
Journal:  Thromb Res       Date:  2011-12-23       Impact factor: 3.944

6.  Thrombocytopenia accompanying a reaction to protamine sulfate.

Authors:  J C Horrow
Journal:  Can Anaesth Soc J       Date:  1985-01

7.  The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents.

Authors:  Joanna Miklosz; Bartlomiej Kalaska; Kamil Kaminski; Malgorzata Rusak; Krzysztof Szczubialka; Maria Nowakowska; Dariusz Pawlak; Andrzej Mogielnicki
Journal:  Mar Drugs       Date:  2019-09-17       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.